Aaron Schueneman

Hematology | Oncology

308 Deep South Farm Rd Ste 200
Blairsville, GA 30512

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma.

Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma.

Journal: BMC cancer

Published: December 04, 2015

Endogenous T-Cell Therapy: Clinical Experience.

Endogenous T-Cell Therapy: Clinical Experience.

Journal: Cancer journal (Sudbury, Mass.)

Published: November 21, 2015

Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.

Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.

Journal: British journal of cancer

Published: March 02, 2015

Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.

Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.

Journal: Annals of surgical oncology

Published: June 11, 2013

Showing 1-4 of 4

Last Updated: 09/26/2026